Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's disease

Copyright © 2024 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 264(2024) vom: 10. Juni, Seite 110241
1. Verfasser: Boudjeniba, Cheïma (VerfasserIn)
Weitere Verfasser: Soret, Perrine, Trutschel, Diana, Hamon, Antoine, Baloche, Valentin, Chassagnol, Bastien, Desvaux, Emiko, Bichat, Antoine, Aussy, Audrey, Moingeon, Philippe, Lefebvre, Céline, Hubert, Sandra, Alarcon-Riquelmé, Marta, Ng, Wan-Fai, Gottenberg, Jacques-Eric, Schwikowski, Benno, Bombardieri, Michele, van Roon, Joel A G, Mariette, Xavier, Guedj, Mickaël, Birmele, Etienne, Laigle, Laurence, Becht, Etienne
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Integrated analysis Precision medicine Sjögren disease Unsupervised learning Biomarkers Hydroxychloroquine 4QWG6N8QKH
LEADER 01000caa a22002652 4500
001 NLM372240542
003 DE-627
005 20240615233634.0
007 cr uuu---uuuuu
008 240513s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2024.110241  |2 doi 
028 5 2 |a pubmed24n1441.xml 
035 |a (DE-627)NLM372240542 
035 |a (NLM)38735508 
035 |a (PII)S1521-6616(24)00350-4 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Boudjeniba, Cheïma  |e verfasserin  |4 aut 
245 1 0 |a Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's disease 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 14.06.2024 
500 |a Date Revised 14.06.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2024 Elsevier Inc. All rights reserved. 
520 |a Primary Sjögren disease (pSD) is an autoimmune disease characterized by lymphoid infiltration of exocrine glands leading to dryness of the mucosal surfaces and by the production of autoantibodies. The pathophysiology of pSD remains elusive and no treatment with demonstrated efficacy is available yet. To better understand the biology underlying pSD heterogeneity, we aimed at identifying Consensus gene Modules (CMs) that summarize the high-dimensional transcriptomic data of whole blood samples in pSD patients. We performed unsupervised gene classification on four data sets and identified thirteen CMs. We annotated and interpreted each of these CMs as corresponding to cell type abundances or biological functions by using gene set enrichment analyses and transcriptomic profiles of sorted blood cell subsets. Correlation with independently measured cell type abundances by flow cytometry confirmed these annotations. We used these CMs to reconcile previously proposed patient stratifications of pSD. Importantly, we showed that the expression of modules representing lymphocytes and erythrocytes before treatment initiation is associated with response to hydroxychloroquine and leflunomide combination therapy in a clinical trial. These consensus modules will help the identification and translation of blood-based predictive biomarkers for the treatment of pSD 
650 4 |a Journal Article 
650 4 |a Integrated analysis 
650 4 |a Precision medicine 
650 4 |a Sjögren disease 
650 4 |a Unsupervised learning 
650 7 |a Biomarkers  |2 NLM 
650 7 |a Hydroxychloroquine  |2 NLM 
650 7 |a 4QWG6N8QKH  |2 NLM 
700 1 |a Soret, Perrine  |e verfasserin  |4 aut 
700 1 |a Trutschel, Diana  |e verfasserin  |4 aut 
700 1 |a Hamon, Antoine  |e verfasserin  |4 aut 
700 1 |a Baloche, Valentin  |e verfasserin  |4 aut 
700 1 |a Chassagnol, Bastien  |e verfasserin  |4 aut 
700 1 |a Desvaux, Emiko  |e verfasserin  |4 aut 
700 1 |a Bichat, Antoine  |e verfasserin  |4 aut 
700 1 |a Aussy, Audrey  |e verfasserin  |4 aut 
700 1 |a Moingeon, Philippe  |e verfasserin  |4 aut 
700 1 |a Lefebvre, Céline  |e verfasserin  |4 aut 
700 1 |a Hubert, Sandra  |e verfasserin  |4 aut 
700 1 |a Alarcon-Riquelmé, Marta  |e verfasserin  |4 aut 
700 1 |a Ng, Wan-Fai  |e verfasserin  |4 aut 
700 1 |a Gottenberg, Jacques-Eric  |e verfasserin  |4 aut 
700 1 |a Schwikowski, Benno  |e verfasserin  |4 aut 
700 1 |a Bombardieri, Michele  |e verfasserin  |4 aut 
700 1 |a van Roon, Joel A G  |e verfasserin  |4 aut 
700 1 |a Mariette, Xavier  |e verfasserin  |4 aut 
700 1 |a Guedj, Mickaël  |e verfasserin  |4 aut 
700 1 |a Birmele, Etienne  |e verfasserin  |4 aut 
700 1 |a Laigle, Laurence  |e verfasserin  |4 aut 
700 1 |a Becht, Etienne  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 264(2024) vom: 10. Juni, Seite 110241  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:264  |g year:2024  |g day:10  |g month:06  |g pages:110241 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2024.110241  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 264  |j 2024  |b 10  |c 06  |h 110241